Management of Polycystic Ovary Syndrome in India

Abstract

One of the most prevalent endocrinopathies affecting women is polycystic ovarian syndrome, or PCOS.[1] It is recognised
as a heterogeneous illness with an uncertain aetiology that causes excess androgen production, mostly from the ovary, and
is linked to insulin resistance (IR).[1] According to the Rotterdam 2003 criteria, polycystic ovaries (PCO), increased
androgen activity, and oligoovulation and/or anovulation are the three main factors that diagnose PCOS.[1,2] However, in
order to accurately portray the clinical character of PCOS, the language employed in this context has to be reviewed.
PCOS prevalence in convenience sample studies conducted in India ranged from 3.7% to 22.5% [3,4], with a prevalence
of 9.13% to 36% among teenagers alone.[5, 6] Age ranges, ethnic populations under study, diagnostic criteria used,
difficulties in diagnosis, and varied symptom presentation might all contribute to the large difference in frequency.
Therefore, before diagnosis and/or treatment are started, these aspects must be taken into account. To comprehend the
dynamics of PCOS incidence rates across India, further research is required. Despite the lack of information from
extensive surveillance studies, the increased prevalence of PCOS risk factors (high body mass index)